More Globe Newswire

View Older Stories View Newer Stories

Oct 1, 2026 04:00AM FTI Consulting Expands UK Turnaround & Restructuring Capabilities With Four Senior Hires
Oct 1, 2026 03:40AM Ress Life Investments A/S publishes Net Asset Value (NAV).
Oct 1, 2026 03:30AM Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer to Advance its Proprietary Multispecific Antibody Pipeline
Oct 1, 2026 03:30AM Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body composition
Oct 1, 2026 03:30AM DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform
Oct 1, 2026 03:30AM Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and
Oct 1, 2026 03:30AM Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
Oct 1, 2026 03:26AM CROSSVOLUTION Is Coming: OMODA X to Make Its Global Debut on October 20, Opening Up New Possibilities for Crossover
Oct 1, 2026 03:15AM Inseego Completes Acquisition of Nokia’s Fixed Wireless Access Business
Oct 1, 2026 03:05AM CallTower Transforms Its Global Communications Platform Through Acquisition of Momentum Telecom’s Voice and Collaboration Business
Oct 1, 2026 03:00AM SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe
Oct 1, 2026 03:00AM StoneX and Cotlook to Launch New OTC Cotton Derivatives
Oct 1, 2026 03:00AM Offentliggørelse af prospekt for Investeringsforeningen Nordea Invest
Oct 1, 2026 03:00AM Offentliggørelse af prospekt, Investeringsforeningen Wealth Invest
Oct 1, 2026 02:54AM ICEYE and Nokia partner to launch secure and sovereign satellite communications for governments and defense customers
Oct 1, 2026 02:37AM EMGA's continued success in Brazil
Oct 1, 2026 02:37AM EMGA's continued success in Brazil
Oct 1, 2026 02:30AM Michelin: Disclosure of trading in own shares - October 1st, 2026
Oct 1, 2026 02:15AM KPN announces changes to Board of Management and Supervisory Board
Oct 1, 2026 02:00AM Pulsar Helium Signs and Accepts Chart Industries Firm Proposal for Commercial-Scale Helium Liquefaction Plant
Oct 1, 2026 02:00AM CompoSecure Opens New London Design Centre to Meet Growing International Demand for Premium Metal Cards
Oct 1, 2026 02:00AM Kobalt Founder Willard Ahdritz Launches Ahdritz Capital Partners With Stephen Langer and Isabel Keulen
Oct 1, 2026 02:00AM Vicat - Proposed Acquisition by Vicat Group of Cemex Group's Ready-Mix Concrete and Aggregates Businesses in South-Eastern France
Oct 1, 2026 02:00AM 2026 Nanoq Drilling Programme Completed and Initial Positive Metallurgical Test Work Results
Oct 1, 2026 02:00AM Stolt-Nielsen Limited Reports Unaudited Results For the Third Quarter and Nine Months of 2026
Oct 1, 2026 02:00AM Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions
Oct 1, 2026 02:00AM Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS
Oct 1, 2026 02:00AM NBPE announces Total Voting Rights
Oct 1, 2026 02:00AM Total Voting Rights
Oct 1, 2026 02:00AM NBPE Announces Transaction in Own Shares
Oct 1, 2026 02:00AM Mironid successfully doses initial cohorts in Phase 1 clinical trial investigating the Company’s first-in-class LoAc® small molecule for patients with ADPKD
Oct 1, 2026 02:00AM Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS
Oct 1, 2026 02:00AM Transaction in Own Shares
Oct 1, 2026 02:00AM Total Voting Rights and Capital
Oct 1, 2026 02:00AM BLOCK LISTING INTERIM REVIEW
Oct 1, 2026 01:00AM Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies
Oct 1, 2026 01:00AM WTW Confirms Change in Ownership of Al-Futtaim Willis
Oct 1, 2026 01:00AM Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies
Oct 1, 2026 01:00AM Start of Day Message
Oct 1, 2026 01:00AM Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine
Oct 1, 2026 01:00AM DRIVING GROWTH THROUGH ADHESIVE SYSTEMS, INNOVATION, AND DIGITAL MARKET LEADERSHIP
Oct 1, 2026 01:00AM dsm-firmenich completes €540 million share repurchase program
Oct 1, 2026 01:00AM IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS®
Oct 1, 2026 12:15AM NIO Inc. Provides September and Third Quarter 2026 Delivery Update
Oct 1, 2026 12:00AM Honeywell Aerospace Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Honeywell Aerospace, Inc. - HONA
Oct 1, 2026 12:01AM National MS Society Launches Campaign to End MS, Declaring for the First Time: Ending MS Is Within Reach
Sep 30, 2026 11:57PM Simply Good Foods Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Simply Good Foods Company - SMPL
Sep 30, 2026 11:55PM HDFC Bank Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against HDFC Bank Limited - HDB
Sep 30, 2026 11:53PM York Space Systems Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against York Space Systems, Inc. - YSS
Sep 30, 2026 11:49PM Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
View Newer Stories View Older Stories